Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | HBEGF |
| Upstream (Parents) |
|---|
| (<<) S100A6 → HBEGF |
| (<<) MAFF → HBEGF |
| (<<) S100A11 → HBEGF |
| (<<) ASAP2 → HBEGF |
| (<<) FHL2 → HBEGF |
| Downstream (Children) |
|---|
| HBEGF → RBMS2 (>>) |
| HBEGF → MMP1 (>>) |
| HBEGF → PMEPA1 (>>) |
| HBEGF → DUSP4 (>>) |
| HBEGF → SLC4A7 (>>) |
| HBEGF → LOC283079 (>>) |
| HBEGF → CRIP1 (>>) |
| HBEGF → CD47 (>>) |
| HBEGF → PRSS50 (>>) |
| HBEGF → NPTX1 (>>) |
| HBEGF → AMIGO2 (>>) |
| HBEGF → FAM5B (>>) |
| HBEGF → NUP88 (>>) |
| HBEGF → TNFRSF12A (>>) |
| HBEGF → GCK (>>) |
| HBEGF → PLK3 (>>) |
| HBEGF → EMP1 (>>) |
| HBEGF → TGFBI (>>) |
| HBEGF → SSX5 (>>) |
| HBEGF → CLDN9 (>>) |
| HBEGF → NBEAL2 (>>) |
